Privat Sygeplejerske ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  0.0% 3.6% 5.8% 10.2% 6.5%  
Credit score (0-100)  0 52 38 23 35  
Credit rating  N/A BBB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 3,841 5,257 4,999 12,101  
EBITDA  0.0 1,396 230 -198 731  
EBIT  0.0 1,396 230 -198 731  
Pre-tax profit (PTP)  0.0 1,392.6 221.3 -206.1 732.7  
Net earnings  0.0 1,081.0 171.0 -205.7 607.0  
Pre-tax profit without non-rec. items  0.0 1,393 221 -206 733  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 1,121 211 5.2 612  
Interest-bearing liabilities  0.0 217 325 503 192  
Balance sheet total (assets)  0.0 1,930 1,192 1,162 1,111  

Net Debt  0.0 -1,583 -553 -434 -783  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 3,841 5,257 4,999 12,101  
Gross profit growth  0.0% 0.0% 36.9% -4.9% 142.0%  
Employees  0 3 5 4 11  
Employee growth %  0.0% 0.0% 66.7% -20.0% 175.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,930 1,192 1,162 1,111  
Balance sheet change%  0.0% 0.0% -38.2% -2.5% -4.4%  
Added value  0.0 1,396.3 230.4 -197.9 730.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 -1.0 1.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 36.4% 4.4% -4.0% 6.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 72.3% 14.8% -16.8% 64.6%  
ROI %  0.0% 104.4% 24.6% -37.9% 111.8%  
ROE %  0.0% 96.4% 25.7% -190.3% 196.6%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 58.1% 17.7% 0.5% 55.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -113.4% -239.9% 219.5% -107.2%  
Gearing %  0.0% 19.3% 153.8% 9,613.0% 31.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 3.4% 3.4% 2.0% 0.4%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 2.4 1.2 1.0 2.2  
Current Ratio  0.0 2.4 1.2 1.0 2.2  
Cash and cash equivalent  0.0 1,799.4 877.2 937.6 975.3  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 1,121.0 211.0 5.2 612.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 465 46 -49 66  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 465 46 -49 66  
EBIT / employee  0 465 46 -49 66  
Net earnings / employee  0 360 34 -51 55